Peter Rahal, Co-founder and CEO of RXBar, says the company was founded on the transparency of its ingredients, and that purpose led to a $600 million buyout from Kellogg.
Rahal explains why ever ingredient in every product is in bold letters on the front of the package. When the company started out, "people would be like ‘well what is it?'” So they made the answer easy to find.
Rahal discusses RXBAR's $600 million sale to Kellogg, and the future direction of the company, where he will remain as CEO. We talk about the whirlwind the company's evolution has been, given that it was founded in 2013, when Rahal and his co-founder were both broke. Then we look ahead to what's next for the company after the Kellogg buyout.
A historic wave of IPOs is about to hit Wall Street. For the average investor watching from the sidelines, the frenzy can engender fears of missing out.
Applied Aerospace & Defense CEO Trip Ferguson discusses the company's IPO, defense spending, space innovation, and the future of U.S. aerospace manufacturing.
David Fahrenthold, investigative reporter for The New York Times, examines rising costs, contracts, and transparency concerns in Trump's D.C. projects.
Amy Sullivan, President of Bed Bath & Beyond, joins us to discuss the brand’s comeback, its Container Store partnership and the future of home shopping.
